| __timestamp | Amneal Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 241751000 |
| Thursday, January 1, 2015 | 367054000 | 322292000 |
| Friday, January 1, 2016 | 420770000 | 344320000 |
| Sunday, January 1, 2017 | 507476000 | 374644000 |
| Monday, January 1, 2018 | 946588000 | 1820000 |
| Tuesday, January 1, 2019 | 1273376000 | 4000000 |
| Wednesday, January 1, 2020 | 1364130000 | 12000000 |
| Friday, January 1, 2021 | 1324696000 | 11000000 |
| Saturday, January 1, 2022 | 1427596000 | 14000000 |
| Sunday, January 1, 2023 | 1573042000 | 9133000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding cost structures is pivotal. From 2014 to 2023, Amneal Pharmaceuticals, Inc. consistently outpaced Ionis Pharmaceuticals, Inc. in terms of cost of revenue. Amneal's expenses surged by approximately 368%, peaking in 2023, while Ionis experienced a more volatile trajectory, with a notable dip in 2018. This disparity highlights Amneal's aggressive expansion and market penetration strategies, contrasting with Ionis's fluctuating operational costs. Notably, Amneal's cost of revenue in 2023 was nearly 17 times that of Ionis, underscoring its larger scale of operations. As the pharmaceutical industry braces for future challenges, these insights into cost management could be crucial for stakeholders aiming to optimize financial performance.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.